-
Something wrong with this record ?
Efficacy and safety of a third stereotactic radiosurgery for recurrent trigeminal neuralgia: an international, multicenter study
F. De Nigris Vasconcellos, JD. Alzate, E. Mashiach, Y. Meng, B. Santhumayor, K. Bernstein, P. Pichardo-Rojas, A. Dono, EP. Damron, AI. Blanco, Y. Esquenazi, D. Urgosik, J. May, CC. Lee, HC. Yang, P. Kawalec, AM. Kaufmann, D. Mathieu, C....
Language English Country Austria
Document type Journal Article, Multicenter Study
NLK
ProQuest Central
from 1997-01-01
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 1997-01-01
Springer Nature OA/Free Journals
from 1950-02-01
- MeSH
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Trigeminal Neuralgia * surgery MeSH
- Radiosurgery * methods adverse effects MeSH
- Recurrence * MeSH
- Reoperation MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Treatment Outcome MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Multicenter Study MeSH
BACKGROUND AND OBJECTIVES: Trigeminal Neuralgia (TN) is a debilitating facial pain disorder, often necessitating surgical interventions when medication proves insufficient. Stereotactic Radiosurgery (SRS) is an established therapeutic option. Limited studies explored the feasibility of a third SRS procedure. Our study investigates the safety and efficacy of a third SRS procedure for recurrent TN. METHODS: We performed a retrospective analysis across multiple centers using databases collected prospectively. Pain status was evaluated utilizing the BNI Pain Intensity Scales. The Kaplan-Meier method was employed to estimate the time to recurrence, with group comparisons conducted using log-rank tests. Associations were explored using Chi-square and logistic regression models. RESULTS: Ten institutions contributed with a total of 35 patients. A third SRS revealed sustained effectiveness with a pain control rate of 82.7%. The median time to recurrence was 35.5 months. New sensory dysfunction following the third procedure occurred in 22% of patients who had preserved sensory function after the second procedure. When considering those who developed sensory dysfunction after the second procedure, 40% of the entire cohort was affected. There were no significant differences in pain recurrence intervals among the three procedures. A meta-analysis, combining data from previous studies, showed that 89.6% of patients achieved some degree of pain control after a third SRS, with 27.4% experiencing new sensory dysfunction and a median time to recurrence of 31.6 months. CONCLUSION: Our study, the largest on the topic, affirms the sustained effectiveness of a third SRS for TN, providing comparable pain relief to initial procedures. Notably, an extended pain-free interval after the third SRS session was observed. Facial sensory dysfunction emerged as the primary side effect. Larger studies are warranted to explore correlations with demographics and treatment parameters for a comprehensive understanding of repeat SRS in managing recurrent TN.
Department of Neurological Surgery Cleveland Clinic Cleveland OH USA
Department of Neurological Surgery IRCCS Humanitas Research Hospital IRCCS Rozzano Italy
Department of Neurological Surgery Koc University School of Medicine Istanbul Turkey
Department of Neurological Surgery Na Homolce Hospital Prague Czech Republic
Department of Neurological Surgery NYU Langone Health New York NY USA
Department of Neurological Surgery PGIMER Chandigarh India
Department of Neurological Surgery University of Manitoba Winnipeg MB Canada
Department of Neurological Surgery University of Miami Miami FL USA
Department of Neurological Surgery University of Virginia Health System Charlottesville VA USA
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25003811
- 003
- CZ-PrNML
- 005
- 20250206104724.0
- 007
- ta
- 008
- 250121s2024 au f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00701-024-06317-2 $2 doi
- 035 __
- $a (PubMed)39441236
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a au
- 100 1_
- $a De Nigris Vasconcellos, Fernando $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA. fervas1003@gmail.com
- 245 10
- $a Efficacy and safety of a third stereotactic radiosurgery for recurrent trigeminal neuralgia: an international, multicenter study / $c F. De Nigris Vasconcellos, JD. Alzate, E. Mashiach, Y. Meng, B. Santhumayor, K. Bernstein, P. Pichardo-Rojas, A. Dono, EP. Damron, AI. Blanco, Y. Esquenazi, D. Urgosik, J. May, CC. Lee, HC. Yang, P. Kawalec, AM. Kaufmann, D. Mathieu, C. Iorio-Morin, P. Picozzi, A. Franzini, M. Tripathi, S. Peker, Y. Samanci, T. Almeida, C. Benjamin, D. Kondziolka, J. Sheehan
- 520 9_
- $a BACKGROUND AND OBJECTIVES: Trigeminal Neuralgia (TN) is a debilitating facial pain disorder, often necessitating surgical interventions when medication proves insufficient. Stereotactic Radiosurgery (SRS) is an established therapeutic option. Limited studies explored the feasibility of a third SRS procedure. Our study investigates the safety and efficacy of a third SRS procedure for recurrent TN. METHODS: We performed a retrospective analysis across multiple centers using databases collected prospectively. Pain status was evaluated utilizing the BNI Pain Intensity Scales. The Kaplan-Meier method was employed to estimate the time to recurrence, with group comparisons conducted using log-rank tests. Associations were explored using Chi-square and logistic regression models. RESULTS: Ten institutions contributed with a total of 35 patients. A third SRS revealed sustained effectiveness with a pain control rate of 82.7%. The median time to recurrence was 35.5 months. New sensory dysfunction following the third procedure occurred in 22% of patients who had preserved sensory function after the second procedure. When considering those who developed sensory dysfunction after the second procedure, 40% of the entire cohort was affected. There were no significant differences in pain recurrence intervals among the three procedures. A meta-analysis, combining data from previous studies, showed that 89.6% of patients achieved some degree of pain control after a third SRS, with 27.4% experiencing new sensory dysfunction and a median time to recurrence of 31.6 months. CONCLUSION: Our study, the largest on the topic, affirms the sustained effectiveness of a third SRS for TN, providing comparable pain relief to initial procedures. Notably, an extended pain-free interval after the third SRS session was observed. Facial sensory dysfunction emerged as the primary side effect. Larger studies are warranted to explore correlations with demographics and treatment parameters for a comprehensive understanding of repeat SRS in managing recurrent TN.
- 650 12
- $a neuralgie trigeminu $x chirurgie $7 D014277
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a radiochirurgie $x metody $x škodlivé účinky $7 D016634
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a recidiva $7 D012008
- 650 _2
- $a výsledek terapie $7 D016896
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a reoperace $7 D012086
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři nad 80 let $7 D000369
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a multicentrická studie $7 D016448
- 700 1_
- $a Alzate, Juan Diego $u Department of Neurological Surgery, Cleveland Clinic, Cleveland, OH, USA
- 700 1_
- $a Mashiach, Elad $u Department of Neurological Surgery, NYU Langone Health, New York, NY, USA
- 700 1_
- $a Meng, Ying $u Department of Neurological Surgery, NYU Langone Health, New York, NY, USA
- 700 1_
- $a Santhumayor, Brandon $u Department of Neurological Surgery, NYU Langone Health, New York, NY, USA
- 700 1_
- $a Bernstein, Kenneth $u Department of Neurological Surgery, NYU Langone Health, New York, NY, USA
- 700 1_
- $a Pichardo-Rojas, Pavel $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA
- 700 1_
- $a Dono, Antonio $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA
- 700 1_
- $a Damron, Ethan P $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA
- 700 1_
- $a Blanco, Angel I $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA
- 700 1_
- $a Esquenazi, Yoshua $u Vivian L. Smith Department of Neurosurgery at McGovern Medical School, Texas Institute for Restorative Neurotechnologies, UTHealth Houston, 6431 Fannin St, Houston, TX, 77030, USA
- 700 1_
- $a Urgosik, Dusan $u Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a May, Jaromir $u Department of Neurological Surgery, Na Homolce Hospital, Prague, Czech Republic
- 700 1_
- $a Lee, Cheng-Chia $u Department of Neurological Surgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan
- 700 1_
- $a Yang, Huai-Che $u Department of Neurological Surgery, Neurological Institute, Taipei Veteran General Hospital, Taipei, Taiwan
- 700 1_
- $a Kawalec, Philip $u Department of Neurological Surgery, University of Manitoba, Winnipeg, MB, Canada
- 700 1_
- $a Kaufmann, Anthony M $u Department of Neurological Surgery, University of Manitoba, Winnipeg, MB, Canada
- 700 1_
- $a Mathieu, David $u Department of Neurological Surgery, Université de Sherbrooke, Centre de Recherche du CHUS, Sherbrooke, QC, Canada
- 700 1_
- $a Iorio-Morin, Christian $u Department of Neurological Surgery, Université de Sherbrooke, Centre de Recherche du CHUS, Sherbrooke, QC, Canada
- 700 1_
- $a Picozzi, Piero $u Department of Neurological Surgery, IRCCS Humanitas Research Hospital - IRCCS, Rozzano, Italy
- 700 1_
- $a Franzini, Andrea $u Department of Neurological Surgery, IRCCS Humanitas Research Hospital - IRCCS, Rozzano, Italy
- 700 1_
- $a Tripathi, Manjul $u Department of Neurological Surgery, PGIMER, Chandigarh, India
- 700 1_
- $a Peker, Selcuk $u Department of Neurological Surgery, Koc University School of Medicine, Istanbul, Turkey
- 700 1_
- $a Samanci, Yavuz $u Department of Neurological Surgery, Koc University School of Medicine, Istanbul, Turkey
- 700 1_
- $a Almeida, Timoteo $u Department of Neurological Surgery, University of Miami, Miami, FL, USA
- 700 1_
- $a Benjamin, Carolina $u Department of Neurological Surgery, University of Miami, Miami, FL, USA
- 700 1_
- $a Kondziolka, Douglas $u Department of Neurological Surgery, NYU Langone Health, New York, NY, USA
- 700 1_
- $a Sheehan, Jason $u Department of Neurological Surgery, University of Virginia Health System, Charlottesville, VA, USA
- 773 0_
- $w MED00009022 $t Acta neurochirurgica $x 0942-0940 $g Roč. 166, č. 1 (2024), s. 422
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/39441236 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250121 $b ABA008
- 991 __
- $a 20250206104719 $b ABA008
- 999 __
- $a ok $b bmc $g 2263531 $s 1239818
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 166 $c 1 $d 422 $e 20241023 $i 0942-0940 $m Acta neurochirurgica $n Acta Neurochir (Wien) $x MED00009022
- LZP __
- $a Pubmed-20250121